OUR TECHNOLOGY

Directly addressing the inherent limitations of current CRISPR methodologies, our technology seeks to unlock previously unattainable avenues in the development of CRISPR based therapeutics.

TECHNOLOGICAL FEATURES

Unprecedented

Homology-Directed

Repair Rates

Accounts for

Immunogenicity

Unique

RNP Delivery

Validated 

CRISPR Nuclease

"WHAT WILL REPLACE Cas9 IS A HIGH FREQUENCY PRECISION EDITING HDR METHODOLOGY"
 

PROF. GEORGE CHURCH, CRISPR PIONEER

FIND OUT MORE.I

CONTACT US.

AddressIn

Institut NEOMED

7171 Frederick Banting
Saint-Laurent  H4S 1Z9

(Québec) Canada

Email

laurent.ziri@jenthera.com

 

    ©2020 Jenthera Therapeutics.  All Rights Reserved.